Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of chronic hepatitis B in patients from special populations.

Literature DB >> 26033083

Management of chronic hepatitis B in patients from special populations.

Abstract

Here we review the management of chronic hepatitis B (CHB) in four special categories of patients: CHB in pregnancy, in patients on immunosuppressive treatments, in patients undergoing liver transplantation, and in patients coinfected with human immunodeficiency virus (HIV) or hepatitis C virus (HCV).

Entities: Disease Species

Mesh：

Substances：

Year: 2015 PMID： 26033083 PMCID： PMC4448700 DOI： 10.1101/cshperspect.a021527

Source DB: PubMed Journal: Cold Spring Harb Perspect Med ISSN： 2157-1422 Impact factor: 6.915

99 in total

1. An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.

Authors: M Nelson; S Portsmouth; J Stebbing; M Atkins; A Barr; G Matthews; D Pillay; M Fisher; M Bower; B Gazzard
Journal: AIDS Date: 2003-01-03 Impact factor: 4.177

2. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.

Authors: James Fung; Cindy Cheung; See-Ching Chan; Man-Fung Yuen; Kenneth S H Chok; William Sharr; Wing-Chiu Dai; Albert C Y Chan; Tan-To Cheung; Simon Tsang; Banny Lam; Ching-Lung Lai; Chung-Mau Lo
Journal: Gastroenterology Date: 2011-07-14 Impact factor: 22.682

3. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users.

Authors: J R Pallás; C Fariñas-Alvarez; D Prieto; M Delgado-Rodríguez
Journal: Eur J Epidemiol Date: 1999-09 Impact factor: 8.082

4. Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma.

Authors: Y Koga; R Kumashiro; K Yasumoto; S Shakado; N Ono; H Noguchi; K Nagata; M Sata; H Abe; N Kaku
Journal: Intern Med Date: 1992-02 Impact factor: 1.271

Review 5. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.

Authors: Srinivas Cheruvu; Kristen Marks; Andrew H Talal
Journal: Clin Liver Dis Date: 2007-11 Impact factor: 6.126

6. Rituximab treatment results in impaired secondary humoral immune responsiveness.

Authors: Lizet E van der Kolk; Joke W Baars; Martin H Prins; Marinus H J van Oers
Journal: Blood Date: 2002-09-15 Impact factor: 22.113

7. Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis.

Authors: R F Harrison; M H Davies; R D Goldin; S G Hubscher
Journal: Histopathology Date: 1993-07 Impact factor: 5.087

8. Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy.

Authors: J K Onwubalili
Journal: Postgrad Med J Date: 1988-04 Impact factor: 2.401

Review 9. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.

Authors: Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal: Int J Rheum Dis Date: 2013-10 Impact factor: 2.454

10. Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

Authors: Ming-Lun Yeh; Chao-Hung Hung; Jee-Fu Huang; Chun-Jen Liu; Chuan-Mo Lee; Chia-Yen Dai; Jing-Houng Wang; Zu-Yau Lin; Sheng-Nan Lu; Tsung-Hui Hu; Ming-Lung Yu; Jia-Horng Kao; Wan-Long Chuang; Pei-Jer Chen; Ding-Shinn Chen
Journal: PLoS One Date: 2011-06-13 Impact factor: 3.240

1 in total

Review 1. Investigational drugs with dual activity against HBV and HIV (Review).

Authors: Shiyu Sun; Qing Yang; Yunjian Sheng; Yi Fu; Changfeng Sun; Cunliang Deng
Journal: Exp Ther Med Date: 2020-11-11 Impact factor: 2.447

1 in total